Engine shutdown: migrastatic strategies and prevention of metastases

Martina Raudenská1, Kateřina Petrláková1, Tamara Juriňáková1

  • 1Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic.

Trends in Cancer
|February 22, 2023
PubMed

Insights

Migrastatic strategies offer a novel approach to combat cancer metastasis by targeting cancer cell migration and invasion. This therapeutic avenue may reduce reliance on high-dose chemotherapy for solid tumors.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Cancer metastasis is the primary cause of mortality in solid tumor patients.
  • Current treatments often involve high-dose cytotoxic therapies to prevent metastatic spread.
  • Migrastatic strategies present a therapeutic alternative by inhibiting cancer cell migration and invasion.

Purpose of the Study:

  • To review anti-invasive and antimetastatic strategies for solid tumor treatment.
  • To highlight the potential of migrastatic therapies in reducing chemotherapy's role.
  • To identify key molecular targets essential for cancer cell motility.

Main Methods:

  • Literature review of anti-invasive and antimetastatic strategies.
  • Analysis of the role of migration machinery in metastatic dissemination.
  • Identification of universal targets for migrastatic therapy.

Main Results:

  • Cancer cell migration and invasion are critical drivers of metastasis.
  • Migrastatic therapies aim to block these processes, potentially lowering chemotherapy requirements.
  • Key targets include ATP availability, mitochondrial metabolism, and cytoskeletal dynamics.

Conclusions:

  • Migrastatic strategies hold significant promise for treating solid tumors.
  • Targeting universal motility mechanisms offers a broad therapeutic window.
  • Further research into these targets could lead to more effective cancer treatments.